<?xml version="1.0" encoding="UTF-8"?>
<p>Ten years of experience will have been gained when the WHO Global Action Plan for Influenza Vaccines concludes in November 2016. Five years of the implementation of the PIP Framework has been reviewed 
 <xref rid="b0110" ref-type="bibr">[22]</xref> and will be discussed by the WHO Member States in January 2017. These provide an opportunity, with engagement of all key players on influenza vaccines, to closely evaluate the achievements and deliberate on critical gaps of pandemic response including the post-GAP deficiencies that should be addressed especially in the context of influenza vaccine production, access and use in the developing world.
</p>
